Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T13:30:43.742Z.
Calculation as of: 2026-10-06T13:30:43.742Z.
Quote observation: 2026-10-06T13:30:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 401df0919e13a39c0e4d05d537d83fb211652c6927e4412e931988a7f945bb4a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Bullfrog AI Holdings, Inc. Common Stock
Market Cap
$10.74M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.21M
EBITDA Yield
N/A
TTM Avg
41.52%
3Y Avg
41.52%
5Y Avg
41.52%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $10.74M | N/A | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.74M | N/A | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.73M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $10.86M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.27M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.21M | N/A | 41.52% | 41.52% | 41.52% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.24M | N/A | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.27M | N/A | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.50M | N/A | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.94M | N/A | N/A | N/A | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute